EMA Withdrawn: Evarrest (human fibrinogen;human thrombin) — Omrix Biopharmaceuticals N. V.

View source ↗

Summary

Evarrest (human fibrinogen; human thrombin) has been withdrawn from EMA authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemostasis Disorders

Drugs mentioned

• EVARREST (fibrin sealant patch)

Snippet

Status: Withdrawn. Therapeutic area: Hemostasis. MAH: Omrix Biopharmaceuticals N. V.. Decision date: 15/11/2017